Compound Detail
CHEMBL407
FLUMAZENIL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL407 |
| Name | FLUMAZENIL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | OFBIFZUFASYYRE-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
20
Targets
88
Activities
4
Assay Types
13
PK Parameters
20
Publications
14
Known Names
11
Indications
1
Mechanisms
Molecular Properties
303.3
MW (Da)
1.77
ALogP
5
HBA
0
HBD
64.4
PSA (Ų)
0.79
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1991 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| GABA-A receptor; anion channel allosteric antagonist | ALLOSTERIC ANTAGONIST | GABA-A receptor; anion channel | ✓ | ✓ |
Indications
Alcoholism Obsessive-Compulsive Disorder Substance-Related Disorders Anxiety Dental Anxiety Disorders of Excessive Somnolence Fragile X Syndrome Idiopathic Hypersomnia Narcolepsy Parkinson Disease Sleep Initiation and Maintenance Disorders
ATC Classification
V03AB25
flumazenil
Level 1: VARIOUS
Level 2: ALL OTHER THERAPEUTIC PRODUCTS
Drug Warnings
Black Box Warning
neurotoxicity
Activity Summary
Ki 79 meas. best 10.05
IC50 5 meas. best 9.3
Kd 3 meas. best 9.35
EC50 1 meas. best 7.52
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 16.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 16.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 16.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 16.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 10.6 | mL.min-1.g-1 | Homo sapiens |
| Cmax | 1120.0 | nM | Homo sapiens |
| F | 20.0 | % | Homo sapiens |
| Fu | 0.5 | - | Homo sapiens |
| Fu | 0.58 | - | Homo sapiens |
| Fu | 0.58 | - | Homo sapiens |
| MRT | 1.0 | hr | Homo sapiens |
| T1/2 | 0.78 | hr | Homo sapiens |
| T1/2 | 0.6 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18973287 | 10.1021/jm800889m | Unchecked | 47 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 10 |
| - | 10.6019/CHEMBL4689842 | U2OS | 9 |
| 12477354 | 10.1021/jm020944u | Mus musculus | 8 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 7 |
| 17626010 | 10.1074/jbc.m702153200 | Unchecked | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 6 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 5 |
| 7799410 | 10.1021/jm00052a019 | GABA A receptor alpha-6/beta-2/gamma-2 | 5 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| 26982523 | 10.1021/acs.jmedchem.6b00034 | Unchecked | 5 |
| 21751815 | 10.1021/jm2001597 | Unchecked | 5 |
Data from ChEMBL 36 via Core Engine